SOLVENTUM CORP (SOLV) Fundamental Analysis & Valuation

NYSE:SOLVUS83444M1018

Current stock price

66.76 USD
+0.64 (+0.97%)
At close:
66.25 USD
-0.51 (-0.76%)
After Hours:

This SOLV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SOLV Profitability Analysis

1.1 Basic Checks

  • SOLV had positive earnings in the past year.
  • SOLV had a positive operating cash flow in the past year.
  • Each year in the past 5 years SOLV has been profitable.
  • In the past 5 years SOLV always reported a positive cash flow from operatings.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • SOLV has a better Return On Assets (10.89%) than 92.39% of its industry peers.
  • SOLV has a Return On Equity of 30.82%. This is amongst the best in the industry. SOLV outperforms 97.83% of its industry peers.
  • SOLV has a Return On Invested Capital of 5.40%. This is in the better half of the industry: SOLV outperforms 76.09% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SOLV is in line with the industry average of 9.18%.
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROIC 5.4%
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • SOLV has a Profit Margin of 18.69%. This is amongst the best in the industry. SOLV outperforms 94.57% of its industry peers.
  • In the last couple of years the Profit Margin of SOLV has grown nicely.
  • SOLV has a Operating Margin of 8.53%. This is in the better half of the industry: SOLV outperforms 75.54% of its industry peers.
  • SOLV's Operating Margin has declined in the last couple of years.
  • The Gross Margin of SOLV (53.57%) is comparable to the rest of the industry.
  • SOLV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 20 40 60

1

2. SOLV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SOLV is destroying value.
  • The number of shares outstanding for SOLV has been increased compared to 1 year ago.
  • The debt/assets ratio for SOLV has been reduced compared to a year ago.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • SOLV has an Altman-Z score of 1.73. This is a bad value and indicates that SOLV is not financially healthy and even has some risk of bankruptcy.
  • SOLV has a Altman-Z score (1.73) which is comparable to the rest of the industry.
  • SOLV has a Debt/Equity ratio of 1.00. This is a neutral value indicating SOLV is somewhat dependend on debt financing.
  • SOLV has a worse Debt to Equity ratio (1.00) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACC0.53
WACC10.27%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that SOLV should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.23, SOLV is not doing good in the industry: 83.15% of the companies in the same industry are doing better.
  • SOLV has a Quick Ratio of 1.23. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SOLV has a Quick ratio of 0.89. This is amonst the worse of the industry: SOLV underperforms 82.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.89
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 1B 2B 3B

4

3. SOLV Growth Analysis

3.1 Past

  • The earnings per share for SOLV have decreased by -8.82% in the last year.
  • SOLV shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.46% yearly.
  • The Revenue has been growing slightly by 0.86% in the past year.
  • Measured over the past years, SOLV shows a small growth in Revenue. The Revenue has been growing by 0.79% on average per year.
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%

3.2 Future

  • SOLV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.04% yearly.
  • SOLV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.77% yearly.
EPS Next Y7.68%
EPS Next 2Y8.46%
EPS Next 3Y9.04%
EPS Next 5YN/A
Revenue Next Year-2.05%
Revenue Next 2Y0.73%
Revenue Next 3Y1.72%
Revenue Next 5Y0.77%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

6

4. SOLV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.94, which indicates a very decent valuation of SOLV.
  • Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 91.85% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. SOLV is valued rather cheaply when compared to this.
  • SOLV is valuated reasonably with a Price/Forward Earnings ratio of 10.16.
  • SOLV's Price/Forward Earnings ratio is rather cheap when compared to the industry. SOLV is cheaper than 94.57% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, SOLV is valued rather cheaply.
Industry RankSector Rank
PE 10.94
Fwd PE 10.16
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SOLV is valued cheaper than 83.15% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.13
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SOLV has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y8.46%
EPS Next 3Y9.04%

0

5. SOLV Dividend Analysis

5.1 Amount

  • No dividends for SOLV!.
Industry RankSector Rank
Dividend Yield 0%

SOLV Fundamentals: All Metrics, Ratios and Statistics

SOLVENTUM CORP

NYSE:SOLV (3/13/2026, 8:04:00 PM)

After market: 66.25 -0.51 (-0.76%)

66.76

+0.64 (+0.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners73.53%
Inst Owner ChangeN/A
Ins Owners0.15%
Ins Owner Change0.31%
Market Cap11.58B
Revenue(TTM)8.32B
Net Income(TTM)1.56B
Analysts75.24
Price Target91.16 (36.55%)
Short Float %2.41%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.79%
Min EPS beat(2)2.66%
Max EPS beat(2)2.92%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)8
Avg EPS beat(8)8.33%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.15%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-0.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.13%
EPS NQ rev (1m)-8.17%
EPS NQ rev (3m)-8.93%
EPS NY rev (1m)1.46%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0.85%
Revenue NQ rev (3m)1.01%
Revenue NY rev (1m)1.21%
Revenue NY rev (3m)1.58%
Valuation
Industry RankSector Rank
PE 10.94
Fwd PE 10.16
P/S 1.39
P/FCF N/A
P/OCF 31.39
P/B 2.29
P/tB N/A
EV/EBITDA 13.13
EPS(TTM)6.1
EY9.14%
EPS(NY)6.57
Fwd EY9.84%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)2.13
OCFY3.19%
SpS47.99
BVpS29.1
TBVpS-18.72
PEG (NY)1.42
PEG (5Y)N/A
Graham Number63.2
Profitability
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROCE 6.36%
ROIC 5.4%
ROICexc 5.87%
ROICexgc 30.39%
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
FCFM N/A
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
ROICexc(3y)8.79%
ROICexc(5y)10.16%
ROICexgc(3y)43.79%
ROICexgc(5y)51.79%
ROCE(3y)9.88%
ROCE(5y)11.65%
ROICexgc growth 3Y-18.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.41%
ROICexc growth 5YN/A
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.2
Cap/Depr 77.51%
Cap/Sales 4.55%
Interest Coverage 1.61
Cash Conversion 30.78%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.89
Altman-Z 1.73
F-Score6
WACC10.27%
ROIC/WACC0.53
Cap/Depr(3y)65.89%
Cap/Depr(5y)57.5%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
EPS Next Y7.68%
EPS Next 2Y8.46%
EPS Next 3Y9.04%
EPS Next 5YN/A
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%
Revenue Next Year-2.05%
Revenue Next 2Y0.73%
Revenue Next 3Y1.72%
Revenue Next 5Y0.77%
EBIT growth 1Y-31.93%
EBIT growth 3Y-24.87%
EBIT growth 5YN/A
EBIT Next Year21.96%
EBIT Next 3Y11.56%
EBIT Next 5YN/A
FCF growth 1Y-101.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.86%
OCF growth 3Y-39.65%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


Can you provide the profitability details for SOLVENTUM CORP?

SOLVENTUM CORP (SOLV) has a profitability rating of 7 / 10.


How financially healthy is SOLVENTUM CORP?

The financial health rating of SOLVENTUM CORP (SOLV) is 1 / 10.